These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 30333818)
1. Calcium/Calmodulin Kinase IV Controls the Function of Both T Cells and Kidney Resident Cells. Ferretti AP; Bhargava R; Dahan S; Tsokos MG; Tsokos GC Front Immunol; 2018; 9():2113. PubMed ID: 30333818 [TBL] [Abstract][Full Text] [Related]
6. Comparative transcriptome analysis reveals a potential role for CaMK4 in γδT17 cells from systemic lupus erythematosus patients with lupus nephritis. Du B; Fan X; Lei F; Zhang S; Li G; Xi X Int Immunopharmacol; 2020 Mar; 80():106139. PubMed ID: 31978801 [TBL] [Abstract][Full Text] [Related]
7. Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus. Koga T; Ichinose K; Mizui M; Crispín JC; Tsokos GC J Immunol; 2012 Oct; 189(7):3490-6. PubMed ID: 22942433 [TBL] [Abstract][Full Text] [Related]
8. The role of CaMK4 in immune responses. Koga T; Kawakami A Mod Rheumatol; 2018 Mar; 28(2):211-214. PubMed ID: 29252071 [TBL] [Abstract][Full Text] [Related]
9. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus. Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889 [TBL] [Abstract][Full Text] [Related]
10. Fasudil compensates podocyte injury via CaMK4/Rho GTPases signal and actin cytoskeleton-dependent activation of YAP in MRL/lpr mice. Tian F; Huang S; Xu W; Xie G; Gan Y; Huang F; Fan Y; Bao J Int Immunopharmacol; 2023 Jun; 119():110199. PubMed ID: 37094544 [TBL] [Abstract][Full Text] [Related]
11. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. Ichinose K; Juang YT; Crispín JC; Kis-Toth K; Tsokos GC Arthritis Rheum; 2011 Feb; 63(2):523-9. PubMed ID: 20954187 [TBL] [Abstract][Full Text] [Related]
12. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice. Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059 [TBL] [Abstract][Full Text] [Related]
13. Cutting edge: Calcium/Calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis. Ichinose K; Rauen T; Juang YT; Kis-Toth K; Mizui M; Koga T; Tsokos GC J Immunol; 2011 Dec; 187(11):5500-4. PubMed ID: 22031763 [TBL] [Abstract][Full Text] [Related]
14. Understanding the pathogenic significance of altered calcium-calmodulin signaling in T cells in autoimmune diseases. Koga T Clin Immunol; 2024 May; 262():110177. PubMed ID: 38460894 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of calcium/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis. Koga T; Umeda M; Yoshida N; Satyam A; Jha M; Scherlinger M; Bhargava R; Tsokos MG; Sato T; Furukawa K; Endo Y; Fukui S; Iwamoto N; Abiru N; Okita M; Ito M; Kawakami A; Tsokos GC Rheumatology (Oxford); 2023 Feb; 62(2):861-871. PubMed ID: 35781320 [TBL] [Abstract][Full Text] [Related]
16. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice. Otomo K; Koga T; Mizui M; Yoshida N; Kriegel C; Bickerton S; Fahmy TM; Tsokos GC J Immunol; 2015 Dec; 195(12):5533-7. PubMed ID: 26561550 [TBL] [Abstract][Full Text] [Related]
17. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4. Shui B; Xia W; Wen C; Ding X J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132 [TBL] [Abstract][Full Text] [Related]
18. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance. Koga T; Hedrich CM; Mizui M; Yoshida N; Otomo K; Lieberman LA; Rauen T; Crispín JC; Tsokos GC J Clin Invest; 2014 May; 124(5):2234-45. PubMed ID: 24667640 [TBL] [Abstract][Full Text] [Related]
19. CaMK4: Structure, physiological functions, and therapeutic potential. Xu H; Yong L; Gao X; Chen Y; Wang Y; Wang F; Hou X Biochem Pharmacol; 2024 Jun; 224():116204. PubMed ID: 38615920 [TBL] [Abstract][Full Text] [Related]